Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Abroad (travel likely)RecruitingPHASE2

Conditions

Cachexia; Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Samsung Medical Center, Seoul, Gangnam-gu, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (YouYoung Lee, MD, PhD)
  • National Cancer Center, Gyeonggi-do, Goyang-si, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (MyungCheol Lim, MD, PhD)
  • Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeong-si, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (JungHye Kwon, MD, PhD)
  • Seoul ST. Mary's hospital, Seoul, Seocho-gu, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (MyungAh Lee, MD, PhD)
  • Korea University Anam Hospital, Seoul, Seongbuk-gu, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (YunJi Choi, MD, PhD)
  • Ajou University Hospital, Gyeonggi-do, Suwon-si, South Korea

    Contact: Study coordinator (Hanim Park) · park.hanim@lskglobal.com · +82 10 3550 3718
    Contact: Principal Investigator (SeokYun Kang, MD, MS)